What I remember that was a solid pattern was cytodyn would do a warrant offer and current warrant holders would exercise the warrants, sell the stock and put the money into the new warrant offer getting more warrants than before. not sure how many were doing this but it was a well known practice and was part of the pitch by Paulson to attract investors. this put huge pressure on the stock price as there are so many warrants.

Nader did try and offer a better deal to warrant holders to exercise at one point to raise cash without doing a new warrant offer but i think it did not work very well.

I would guess that this time might be a better time because there are likely more warrants expiring and greater confidence in the future of the company. If it works well enough, there will be fewer outstanding warrants and more long term holders of the stock. This could set a better stock price foundation and fade away stock price levels that are created by warrant strike prices.

I hope it works well and the need to keep the stock price low for warrant holder looking to collect more shares for the same money or Fife at streeterville wanting to get paid back with as many shares as possible might be gone.

It does show how aggressive Nader had to be to get funding to move forward. It really upsets me that the FDA does not realize what a company has to do to get through a trial and get approved even when the drug shows nothing but perfection. As many have criticized Nader for these deals, what choice did he have when Dr J is now in the same boat trying to get a trial going.